Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Emily S. Brouwer, MPH, PharmD, PhD
Vice President
Epidemiology and Real-World Science, Parexel
Poster(s):
(008) Comparing regulatory guidance on risk mitigation (or RMM) studies and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies (RIMES) checklist
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(CSPOT29) Assessing use of the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies (RIMES) checklist in risk minimization evaluation studies in the EUPAS register
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
